To process database of the company, the research methodology adopted is collecting data through sources like online journals, regulatory websites, clinical trials sites/registry, regulatory bodies of the countries. • Extensive and intensive analysis of each of existing pipeline and new products on ongoing basis, from various perspectives, including financial, commercial, technical, IP/patent, generic, life cycle management • Converting raw data into client required format. • Gathering data from various sources (clinicaltrials.gov, PubMed etc) to analyze and compile reports. • Analyze research publications, company press releases, SEC Files (U.S. Securities and Exchange Commission), clinical trials, fact sheets and other modes information to identify and report key industry insights and trends. • Tracking the pipeline of the companies and collecting the data about the products from the pipeline. Principles of Good Clinical Practice, Informed Consent form (ICF), Subject Screening, Source Documentation, Adverse Events & Serious Adverse events Reporting, EC commission, Drug Accountability, Sample Packing, and Shipping to central lab, performing IVRS (Interactive Voice Response System) & IWRS (Interactive Web Response System), entering e-CRF (manual & electronic), notification of SUSAR's, maintaining IMF & many other trial related activities.